Improving adherence to treatment guidelines: A blueprint

Critical Pathways in Cardiology

Volumn 8, Issue 4, 2009, Pages 139-145

  Gandara, Esteban ^a,b   Moniz, Thomas T ^a,c   Dolan, Mary Lou ^a   Melia, Caroline ^a   Dudley, Jessica ^a,b   Smith, Allen ^a,b   Kachalia, Allen ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Chronic disease; Guideline adherence; Quality of health care

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; WARFARIN;

AMBULATORY CARE; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG INDICATION; E-MAIL; ELECTRONIC MEDICAL RECORD; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFORMATION DISSEMINATION; ISCHEMIA; KIDNEY FAILURE; MEDICAL SPECIALIST; MICROALBUMINURIA; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; TRANSIENT ISCHEMIC ATTACK; PLUS DIPYRIDAMOLE;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS; DRUG UTILIZATION; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; KIDNEY DISEASES; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT;

EID: 75949090900     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e3181bc8074     Document Type: Review

References (33)

1. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the national heart, lung, and blood institute. Circulation. 2006;113:2363-2372.
2. Hunt SA; American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol. 2005;46:e1-e82.
3. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 suppl 1):S1-S290.
4. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care. 2006;29(suppl 1):S4-S42.
5. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke. Co-sponsored by the council on cardiovascular radiology and intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577-617. (Pubitemid 43732031)
6. Akincigil A, Bowblis JR, Levin C, et al. Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction. J Gen Intern Med. 2008;23:115-121.
7. Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidencebased secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203-212.
8. Anderson RE, Brismar K, Ivert T. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines. Diab Vasc Dis Res. 2007;4:112-116.
9. Foote SB, Town RJ. Implementing evidence-based medicine through medicare coverage decisions. Health Aff (Millwood). 2007;26:1634-1642.
10. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717-727.
11. Matchar DB, Samsa GP, Cohen SJ, et al. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial. Am J Med. 2002;113:42-51.
12. Partington SL, Abid S, Teo K, et al. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy. Thromb Res. 2007;120:663-669.
13. Tobe SW, Pylypchuk G, Wentworth J, et al. Effect of nurse-directed hypertension treatment among first nations people with existing hypertension and diabetes mellitus: the diabetes risk evaluation and microalbuminuria (DREAM 3) randomized controlled trial. CMAJ. 2006;174:1267-1271.
14. Reiber GE, Au D, McDonell M, et al. Diabetes quality improvement in department of veterans affairs ambulatory care clinics: a group-randomized clinical trial. Diabetes Care. 2004;27(suppl 2):B61-B68.
15. Perria C, Mandolini D, Guerrera C, et al. Implementing a guideline for the treatment of type 2 diabetics: results of a cluster-randomized controlled trial (C-RCT). BMC Health Serv Res. 2007;7:79.
16. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716-724.
17. Matchar DB. Do anticoagulation management services improve care? Implications of the managing anticoagulation services trial. Card Electrophysiol Rev. 2003;7:379-381.
18. Phillips LS, Twombly JG. It's time to overcome clinical inertia. Ann Intern Med. 2008;148:783-785.
19. Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23:588-594.
20. Roumie CL, Elasy TA, Wallston KA, et al. Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf. 2007;33:277-285.
21. Puder JJ, Keller U. Quality of diabetes care: problem of patient or doctor adherence? Swiss Med Wkly. 2003;133:530-534.
22. Turner BJ, Hollenbeak CS, Weiner M, et al. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148:578-586.
23. Gonzalez-Juanatey JR, Alegria-Ezquerra E, Aznar-Costa J, et al. Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists. Rev Esp Cardiol. 2006;59:801-806.
24. Azizi M, Menard J, Peyrard S, et al. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl ser-asp-lyspro determination in the noninsulin-dependent diabetes, hypertension, microalbuminuria, proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study. Diabetes Care. 2006;29:1331-1336.
25. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857-2867.
26. Fharm E, Rolandsson O, Weinehall L. Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence. Scand J Public Health. 2008;36:69-75.
27. Naik AD, Kallen MA, Walder A, et al. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication. Circulation. 2008;117:1361-1368.
28. Landon BE, Hicks LS, O'Malley AJ, et al. Improving the management of chronic disease at community health centers. N Engl J Med. 2007;356:921-934.
29. Fretheim A, Oxman AD, Havelsrud K, et al. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention. PLoS Med. 2006;3:e134.
30. Roumie CL, Elasy TA, Greevy R, et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med. 2006;145:165-175.
31. Akosah KO, Schaper AM, Haus LM, et al. Improving outcomes in heart failure in the community: long-term survival benefit of a disease-management program. Chest. 2005;127:2042-2048.
32. LaBresh KA, Ellrodt AG, Gliklich R, et al. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004; 164:203-209.
33. Kiefe CI, Allison JJ, Williams OD, et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA. 2001;285:2871-2879.